FDA Greenlights Linaclotide (Linzess) for Children 7 Years and Older with Irritable Bowel Syndrome with Constipation
Ironwood's Linzess is the first FDA-approved drug for children 7+ with IBS-C (chronic constipation, pain, and bloating).
Ironwood's Linzess is the first FDA-approved drug for children 7+ with IBS-C (chronic constipation, pain, and bloating).
Ironwood shares climb after AbbVie reports strong Q3 Linzess sales of $315M, surpassing estimates and boosting investor confidence.